Many STAT3 target genes have been shown to promote inflammation, immune‐escape, tumour invasion and metastasis by up‐regulating cytokines, such as IL‐6, making STAT3 a target of interest in cancer therapy.3, 14. The gene discussed is STAT3; the disease is neoplasm.